Some cancer treatments target certain proteins in cancer cells to stop the cancer cells growing, dividing and spreading. These targeted therapies have dramatically improved the outcomes of many people with cancer, including those with breast cancer.
Unfortunately, patients can develop resistance to targeted therapies and then the drugs no longer work as they should.
This is a major clinical problem for breast cancer patients, so new approaches to overcome it are desperately needed.
Adam Byron 